Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies

Author： Mahadevan Daruka   Sutton Gregory   Arteta-Bulos Rafael   Bowden Chris   Miller Paul   Swart Rachel   Walker Mark   Haluska Paul   Munster Pamela   Marshall John   Hamid Omid   Kurzrock Razelle  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.73, Iss.3, 2014-03, pp. : 467-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors

By Macaulay V. M.   Middleton M. R.   Protheroe A. S.   Tolcher A.   Dieras V.   Sessa C.   Bahleda R.   Blay J.-Y.   LoRusso P.   Mery-Mignard D.   Soria J.-C.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 784-791

Oxford University Press

Access to resources Recommend Favorite

A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells

By        

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 867-872

Spandidos Publications

Access to resources Recommend Favorite

A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer

By Ma Cynthia  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 145-153

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors

By Wakui Hiroshi   Yamamoto Noboru   Nakamichi Shinji   Tamura Yousuke   Nokihara Hiroshi   Yamada Yasuhide   Tamura Tomohide  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 511-516

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 Results From a Study of Romidepsin in Combination With Gemcitabine in Patients With Advanced Solid Tumors

By Jones Suzanne F.   Infante Jeffrey R.   Spigel David R.   Peacock Nancy W.   Thompson Dana S.   Greco F. Anthony   McCulloch William   Burris III Howard A.  

Cancer Investigation, Vol. 30, Iss. 6, 2012-06 ,pp. : 481-486

Informa Healthcare

Access to resources Recommend Favorite